https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Pain and health-related quality of life (HR-QoL) assessed using the endometriosis health profile (EHP-3 and chronic pain grade (CPG) questionnaires. RESULTS There was no evidence for any significant harmful effects on any of the measured haematological, renal or liver function tests. Although results regarding the effect on BMD are not conclusive there is an increased risk of development of osteopaenia after 12 months of treatment. Pain and HRQoL assessments showed significant improvement during medication, but with
Like
Comment
Share
